- US-listed companies
- T2 Biosystems, Inc.
- Income statement
T2 Biosystems, Inc.TTOO
Market cap
$231.47K
P/E ratio
| 2014/12 | 2015/12 | 2016/12 | 2017/12 | 2018/12 | 2019/12 | 2020/12 | 2021/12 | |
| Revenue | 0 | 3 | - | 5 | 11 | 8 | 18 | 28 |
| Revenue growth (%) | - | - | - | |||||
| Cost of revenue | - | 2 | - | 12 | - | - | - | - |
| Research & development | 20 | 25 | - | 24 | 14 | 16 | 17 | 22 |
| Selling, general & administrative | 11 | 19 | - | 23 | 26 | 27 | 21 | 29 |
| Operating margin (%) | - | |||||||
| Operating income | -31 | -43 | - | -54 | -45 | -52 | -41 | -43 |
| Operating expenses | 31 | 46 | - | 59 | 56 | 60 | 59 | 71 |
| Net income | -31 | -45 | -55 | -62 | -51 | -59 | -47 | -49 |
| Net income margin (%) | - | |||||||
| EBITDA | - | |||||||
| EBITDA margin (%) | - |